The Community Advisory Panel (CAP) is a new mechanism aimed to provide advice to the Medicines Patent Pool (MPP) and its Expert Advisory Group (EAG). Accordingly, community representatives and other individuals with lived experience across a variety of disease areas within MPP’s broad mandate (i.e., HIV, viral hepatitis, TB, malaria, cancer, diabetes, COVID-19, and reproductive, maternal, newborn and child health) are invited to apply.
For detailed information about the call, click here. The deadline for applications is 30 September 2022.